Levonorgestrel
- Generic Name
- Levonorgestrel
- Brand Names
- Afirmelle 28 Day, Aftera, Alesse, Altavera 28 Day, Amethia 91 Day, Amethyst, Ashlyna 91 Day, Aubra 28 Day, Aviane 28, Ayuna 28 Day Pack, Balcoltra 28 Day, Bionafem, Camrese 91 Day, Camreselo 91 Day, Chateal 28 Day, Climara Pro, Curae, Daysee 91 Day, Delyla 28 Day, Dolishale 28 Day, Econtra, Enpresse 28 Day, Fallback Solo, Falmina 28 Day, Fayosim 91 Day, Her Style, Iclevia 91 Day, Indayo, Introvale 91 Day, Jaimiess 91 Day, Jolessa 91 Day, Joyeaux 28 Day, Kurvelo, Kyleena, Larissia 28 Day Pack, Levonest 28 Day, Levora 0.15/30 28 Day, Liletta, Lillow 28 Day, Lo Simpesse, LoJaimiess, Loseasonique, Lutera 28 Day, Marlissa 28 Day, Min-ovral, Mirena, Morning After, My Choice, My Way, Myzilra 28 Day, New Day, Next Choice, Next Choice One Dose, Opcicon One-step, Option 2, Orsythia 28 Day, Plan B, Plan B One-step, Portia 28 Day, Preventeza, Quartette 91 Day Pack, React, Rivelsa 91 Day, Seasonale, Seasonique, Setlakin 91 Day, Simpesse, Skyla, Sronyx 28 Day, Take Action, Triquilar, Trivora 28 Day, Twirla 3 Count Weekly Patch, Tyblume 28 Day, Vienva 28 Day
- Drug Type
- Small Molecule
- Chemical Formula
- C21H28O2
- CAS Number
- 797-63-7
- Unique Ingredient Identifier
- 5W7SIA7YZW
- Background
Levonorgestrel (LNG) is a synthetic progestogen similar to Progesterone used in contraception and hormone therapy. Also known as Plan B, it is used as a single agent in emergency contraception, and as a hormonal contraceptive released from an intrauterine device, commonly referred to as an IUD. Some of these devices are known as Jaydess, Kyleena, and Mirena....
- Indication
Emergency contraception
...
- Associated Conditions
- Endometrial Hyperplasia, Endometriosis, Heavy Menstrual Bleeding, Hypermenorrhea, Postmenopausal Osteoporosis, Pregnancy, Moderate Menopausal Vasomotor Symptoms, Severe Vasomotor Symptoms Associated With Menopause
- Associated Therapies
- Emergency Contraception
Mirena and Estrogen for Control of Perimenopause Symptoms and Ovulation Suppression
- Conditions
- Interventions
- First Posted Date
- 2012-06-06
- Last Posted Date
- 2015-12-02
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 39
- Registration Number
- NCT01613131
- Locations
- 🇺🇸
University of Colorado, Aurora, Colorado, United States
Drug-drug Interaction of BI 201335 and Microgynon
- Conditions
- Interventions
- First Posted Date
- 2012-04-04
- Last Posted Date
- 2015-08-03
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 16
- Registration Number
- NCT01570244
- Locations
- 🇩🇪
1220.56.1 Boehringer Ingelheim Investigational Site, Biberach, Germany
Drug-drug Interaction of Empagliflozin (BI 10773) and Microgynon
- Conditions
- Interventions
- First Posted Date
- 2011-04-04
- Last Posted Date
- 2014-06-18
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 18
- Registration Number
- NCT01328184
- Locations
- 🇩🇪
1245.41.1 Boehringer Ingelheim Investigational Site, Biberach, Germany
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
- First Posted Date
- 2009-10-15
- Last Posted Date
- 2024-08-14
- Lead Sponsor
- Medicines360
- Target Recruit Count
- 1910
- Registration Number
- NCT00995150
- Locations
- 🇺🇸
Magee Women's Hospital, University of Pittsburgh, Pittsburgh, Pennsylvania, United States
Pericoital Oral Contraception With Levonorgestrel
- First Posted Date
- 2009-06-17
- Last Posted Date
- 2013-10-29
- Lead Sponsor
- FHI 360
- Target Recruit Count
- 72
- Registration Number
- NCT00922233
- Locations
- 🇺🇸
Planned Parenthood of the Rocky Mountains, Denver, Colorado, United States
🇺🇸Planned Parenthood Gulf Coast, Inc., Houston, Texas, United States
🇧🇷CEMICAMP, Campinas, Brazil
Copper T380 IUD Versus Oral Levonorgestrel for Emergency Contraception vs. Plan B for Emergency Contraception
- First Posted Date
- 2008-04-30
- Last Posted Date
- 2014-12-22
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 57
- Registration Number
- NCT00669396
- Locations
- 🇺🇸
Planned Parenthood Association of Utah, West Valley City Clinic, West Valley City, Utah, United States
Safety and Efficacy of CDB-2914 in Comparison to Levonorgestrel for Emergency Contraception
- First Posted Date
- 2007-10-31
- Last Posted Date
- 2022-05-03
- Lead Sponsor
- HRA Pharma
- Target Recruit Count
- 2221
- Registration Number
- NCT00551616
- Locations
- 🇺🇸
Planned Parenthood of the Rocky Mountains, Littleton, Colorado, United States
🇺🇸Planned Parenthood of Texas Capitol Region, Austin, Texas, United States
🇺🇸Planned Parenthood of Northeast Ohio Rocky River Health Center, Rocky River, Ohio, United States
HR-QoL and Sexuality in Mirena Inserted Contraception Users
- First Posted Date
- 2007-07-10
- Last Posted Date
- 2013-01-23
- Lead Sponsor
- Bayer
- Target Recruit Count
- 141
- Registration Number
- NCT00498784
Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer
- Conditions
- Interventions
- First Posted Date
- 2007-03-09
- Last Posted Date
- 2019-11-19
- Lead Sponsor
- Gynecologic Oncology Group
- Target Recruit Count
- 60
- Registration Number
- NCT00445887
- Locations
- 🇺🇸
Elkhart Clinic, Elkhart, Indiana, United States
🇺🇸Michiana Hematology Oncology PC-South Bend, South Bend, Indiana, United States
🇺🇸University of Texas Medical Branch, Galveston, Texas, United States
European Active Surveillance Study (EURAS)
- Conditions
- Interventions
- First Posted Date
- 2006-03-15
- Last Posted Date
- 2009-11-20
- Target Recruit Count
- 59510
- Registration Number
- NCT00302848
- Locations
- 🇩🇪
Center for Epidemiology and Health Research, Berlin, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.